T2s Group Holding SA (T2S)

Currency in MAD
242.20
-0.80(-0.33%)
Closed·
Advertisement
T2S is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
241.05246.00
52 wk Range
237.05267.55
Key Statistics
Bid/Ask
240.70 / 244.90
Prev. Close
243
Open
243.1
Day's Range
241.05-246
52 wk Range
237.05-267.55
Volume
26.51K
Average Volume (3m)
121.6K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
T2S Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare T2S to Peers and Sector

Metrics to compare
T2S
Peers
Sector
Relationship
P/E Ratio
0.0x11.9x−0.3x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
0.0x0.7x3.1x
Upside (Analyst Target)
0.0%26.2%48.5%
Fair Value Upside
Unlock28.2%6.3%Unlock

T2S Group Holding distributes, installs, and maintains high-tech equipment, solutions, and services for healthcare professionals in Morocco and Africa. The company operates through the radiology and oncology, ORAS (operating rooms and hospital care), medical devices, laboratory instruments, laboratory reagents, digital systems, and after-sales services segments. It offers medical imaging and radiation therapy equipment, such as CT scanners, MRI scanners, conventional radiology systems, mammography systems, nuclear medicine equipment, radiation therapy accelerators, and radiation therapy robots; equipment for operating rooms, intensive care units, anesthesia systems, sterilization, neuro-navigation, and ultrasound; surgical robots, minimally invasive and laparoscopic surgical instruments, implantable devices, and consumables for diagnostic and therapeutic procedures in cardiology, radiology, oncology, gastrointestinal endoscopy, and urology; equipment and reagents for laboratories, as well as molecular biology solutions; radiopharmaceuticals, such as PET tracers, contrast agents, and healthcare products for nuclear medicine; hospital and pharmaceutical IT solutions; and technical services for the installation, maintenance, and support of critical medical equipment. It caters to private institutions, including structured private hospital groups, medical practices, clinical laboratories, and independent practitioners; public institutions, including public hospitals, university hospitals, and military hospitals; and ministries of health. The company was founded in 1992 and is based in Casablanca, Morocco. T2S Group Holding operates as a subsidiary of Trone Investment Holdings Limited.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
6.18M52.95%1.50B
Public Companies & Retail Investors
5.49M47.05%1.34B
Total
11.68M100.00%2.84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Helios Investment Partners LLP52.95%6,183,0051,502,470

FAQ

What Is the T2s Holding (Casablanca: T2S) Share Price Today?

The T2s Holding stock price today is 242.20 MAD.

What Stock Exchange Does T2s Holding (T2S) Trade On?

T2s Holding is listed and trades on the Casablanca Stock Exchange.

What Is the Ticker (Stock Symbol) for T2s Holding?

The stock symbol (also called a 'ticker') for T2s Holding is "T2S."

What Is the Current T2s Holding Market Capitalisation?

As of today, T2s Holding (Casablanca: T2S) market cap is 2.83B MAD.

What Is T2s Holding's (T2S) Earnings Per Share (TTM)?

The T2s Holding EPS is currently 7.26 (Trailing Twelve Months).

Is T2S a Buy or Sell From a Technical Analyst Perspective?

Based on today's T2s Holding moving averages and other technical indicators, the daily buy/sell signal for T2S stock is Buy.

How Many Times Has T2s Holding Stock Split?

T2s Holding has split 0 times. (See the T2S stock split history page for full effective split date and price information.)

What is the current trading status of T2s Holding (Casablanca: T2S)?

As of 20/08/2026, T2s Holding (T2S) is trading at a share price of 242.20 MAD, with a previous close of 243.00 MAD. The stock has fluctuated within a day range of 241.05 MAD to 246.00 MAD, while its 52-week range spans from 237.05 MAD to 267.55 MAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.